Live birth rate per woman · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
It is very uncertain whether day 3 changes live birth rate per woman compared with day 2 embryo transfer following IVF or ICSI (very low certainty).
1 finding from 1 review
Ongoing pregnancy · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
It is very uncertain whether day 3 changes ongoing pregnancy rate per woman compared with day 2 embryo transfer following IVF or ICSI (very low certainty).
1 finding from 1 review
Clinical pregnancy rate · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
It is very uncertain whether day 3 changes clinical pregnancy rate per woman compared with day 2 embryo transfer following IVF or ICSI (very low certainty).
1 finding from 1 review
Multiple pregnancy rate · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
Day 3 showed no clear difference in multiple pregnancy rate per woman compared with day 2 embryo transfer following IVF or ICSI (moderate certainty).
1 finding from 1 review
Miscarriage · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
Day 3 showed no clear difference in miscarriage rate per woman compared with day 2 embryo transfer following IVF or ICSI (moderate certainty).
1 finding from 1 review
Complications during pregnancy per woman per couple ‐ ectopic pregnancy4 · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
Day 3 showed no clear difference in ectopic pregnancy rate per woman compared with day 2 embryo transfer following IVF or ICSI (low certainty).
1 finding from 1 review
Intervention not reported
Presence of PDA on day 3 or 4 of life (after 72 hours of treatment) · preterm or low birth weight infants with risk of having PDA on day 3 to 4 of life
The intervention may leads to lower presence of PDA on day 3 or 4 of life (after 72 hours of treatment) (low certainty).
1 finding from 1 review
P. vivax parasitaemia detected > 30 days after starting primaquine · People with P. vivax malaria1
Primaquine five days probably leads to higher P. vivax parasitaemia detected > 30 days after starting primaquine compared with 14 days (moderate certainty).
1 finding from 1 review
P. vivax parasitaemia detected > 30 days after starting primaquine · People with P. vivax malaria1
Primaquine three days probably leads to higher P. vivax parasitaemia detected > 30 days after starting primaquine compared with 14 days (moderate certainty).
1 finding from 1 review
P. vivax parasitaemia detected > 30 days after starting primaquine · People with P. vivax malaria1
Primaquine seven days may leads to higher P. vivax parasitaemia detected > 30 days after starting primaquine compared with 14 days (low certainty).
1 finding from 1 review
Extent of hospital care: 3. duration of day patient care (adjusted days/month) · patients with acute psychiatric disorders
1 finding from 1 review
Extent of hospital care: 5. readmitted to in/day patient care after discharge · patients with acute psychiatric disorders
It is very uncertain whether day hospital changes extent of hospital care: 5. readmitted to in/day patient care after… compared with inpatient (very low certainty).
1 finding from 1 review
Live birth · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes live birth compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Miscarriage · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes miscarriage compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Viable intrauterine Pregnancy · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes viable intrauterine pregnancy compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Ectopic pregnancy · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes ectopic pregnancy compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Stillbirth · people having preimplantation genetic testing for monogenic/single gene defects
1 finding from 1 review
Termination of pregnancy · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes termination of pregnancy compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Eradication of P aeruginosa from the respiratory tract: proportion of participants with a negative culture for PA during the 28 days following treatment · children and adolescents with cystic fibrosis
1 finding from 1 review
Service utilisation outcomes: hospital admission or days in hospital · patients with schizophrenia
1 finding from 1 review